Doctor of Osteopathy Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Jeanwoo Yoo

Clinical Cardiac Electrophysiology Jacksonville, FL Doctor of Osteopathy

NPI 1255836219 CMS profile 11564173

4500 San Pablo Rd S, Jacksonville, FL 32224

Open in the dashboard

General payments

$21,152

156 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jeanwoo Yoo of Jacksonville, FL is reported in the CMS Open Payments database as having received $21,152 across 156 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,256 59
2024 General $12,945 91
2023 General $754 4
2022 General $197 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeanwoo Yoo
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jeanwoo Yoo were reported at $7,256. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jeanwoo Yoo Clinical Cardiac Electrophysiology median Middle half National median
2019 $0 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $0 $1,185 $326–$4,739 $132
2022 $197 $2,073 $554–$6,789 $149
2023 $754 $2,568 $759–$8,159 $160
2024 $12,945 $2,557 $703–$7,403 $164
2025 $7,256 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $4,810 34 payments
  2. Boston Scientific Corporation $4,776 23 payments
  3. Biosense Webster, Inc. $3,720 33 payments
  4. Medical Device Business Services, Inc. $3,059 28 payments
  5. Biotronik Inc. $2,456 13 payments
  6. Medtronic, Inc. $927 7 payments
  7. Abiomed $303 3 payments
  8. Novartis Pharmaceuticals Corporation $209 2 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $197 2 payments
  10. Baxter Healthcare $149 1 payment
  11. Other $546 10 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $12,843 46 payments
  2. Food and Beverage $6,870 103 payments
  3. Education $1,439 7 payments
Products named General payments · program years 2022–2025
  1. Carto 3 $6,681 59 payments
  2. ENSITE Structural Heart $1,951 16 payments
  3. VersaCross Access Solution $1,577 9 payments
  4. ENSITE Electrophysiology $1,037 4 payments
  5. AMVIA EDGE $753 1 payment
  6. PAMIRA $753 1 payment
  7. Solia $753 1 payment
  8. Selectra $753 1 payment
  9. ENSITE PRECISION Electrophysiology $636 10 payments
  10. ENSITE PRECISION Molecular Diagnostics $629 2 payments
  11. Other $2,705 30 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$138

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

0%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Metoprolol Succinate Generic 12 $138

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
WAINUA
  • AstraZeneca Pharmaceuticals LP $122
$122 — —
DEFINITY
  • Lantheus Medical Imaging, Inc. $58
$58 — —
ELIQUIS
  • PFIZER INC. $22
$22 — —
ONPATTRO
  • Alnylam Pharmaceuticals Inc. $20
$20 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

156 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record